Loading provider…
Loading provider…
Allergy & Immunology Physician in York, NE
NPI: 1093707754Primary Practice Location
YORK GENERAL HEALTH CARE SERVICES
2222 N Lincoln Ave, York, NE
Primary Employer
Option Care
optioncareltd.com
HQ Phone
Get M.D. Roger's Phone Numberphone_androidMobile
Get M.D. Roger's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
CA State Medical License
1977
NE State Medical License
1980 - 2024
IA State Medical License
1990 - 2023

American Board of Allergy and Immunology
Allergy & Immunology

American Board of Pediatrics
Pediatrics
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Allergy and Immunology
1977 - 1980
UNMC
unmc.edu
Medical School
Until 1975
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Pediatrics
1975 - 1977
University of Hawaii School of Medicine
Masters • Cardiovascular Physiology
1972 - 1975
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.
Authors: Jose Mandujano, Bob Geng, Sudhir Gupta, Thomas Atkinson
Publication Date: 2018-10-18
Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies.
Authors: Jose Mandujano, Bob Geng, Sudhir Gupta, Thomas Atkinson
Publication Date: 2022-11-28
Candida laryngitis in chronic mucocutaneous candidiasis. Its association with Candida esophagitis.
Authors: Ewald Stiehm, Marvin Ament
Journal: Ann Otol Rhinol Laryngol
Lead Sponsor: Baxalta now part of Shire
Intervention / Treatment: BIOLOGICAL: Immune Globulin Intravenous (Human), 10%
Lead Sponsor: Octapharma
Intervention / Treatment: DRUG: CUTAQUIG
Lead Sponsor: Octapharma
Intervention / Treatment: DRUG: Octanorm 16.5%